Keywords: rhenovia, opens, biosimulation, platform, cns, drug, discovery

Rhenovia opens biosimulation platform for CNS drug discovery

Article | 01 May 2009

Rhenovia Pharma, a Mulhouse, France-based biopharmaceutical company specialized in the development and optimization of treatments for Alzheimer's and other diseases ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Drug Discovery

Go to company listing